ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER – Trademark Portfolio
Entity Type: 03
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include SIDELINE CANCER and ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER. The owner is based in HOLLIDAYSBURG, PA.
309 ALLEGHENY STREET, SUITE 5
HOLLIDAYSBURG, PA 16448
Showing of trademarks Trademarks
Trademark Classifications
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER have?
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER file in?
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER's most well-known trademarks?
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER's registered trademark portfolio includes well-known marks such as SIDELINE CANCER and ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER. These are among 2 currently registered trademarks in the portfolio.
What is ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER's trademark registration success rate?
ALLIANCE OF FAMILIES FIGHTING PANCREATIC CANCER has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.